MOUNTAIN VIEW, Calif., Nov. 28, 2011 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced it has launched Mandarin-language versions of its G4 medication automation products for clinical use in China. The successful language conversion of Omnicell medication cabinets enables Chinese hospitals to access advances in operational improvements similar to those made available in English-speaking markets earlier this year when Omnicell launched its new automation platform. This groundbreaking medication automation system was first implemented at Peking Union Medical College Hospital (PUMCH) in Beijing. A recently completed multi-month pilot study of the Mandarin-language Omnicell automated dispensing cabinets (ADCs) at PUMCH found that the Omnicell ADCs save each floor nurse nearly two hours per day that were previously spent locating medications and which can now be re-directed back to patient care. The hospital has plans to extend its use of Omnicell ADCs to other areas of the hospital. "By automating the medication dispensing and administration process, we are able to store and retrieve medications securely from the Omnicell ADCs on the patient floors, which are restocked automatically by the pharmacy staff," said Weinan Liu, chief nurse, Peking Union Medical College Hospital. "The Omnicell automation process significantly reduces the time our nursing staff spends manually retrieving medications from the central pharmacy. This allows our nurses to focus more time on patient care." In a news segment titled " Return Time to Nurses, Return Nurses to Patients," a China national television network recently featured the Omnicell medication automation advancements at PUMCH as a leading example of improvements being made in the Chinese healthcare system. PUMCH is a renowned 1,800-bed general hospital affiliated with both Peking Union Medical College and the Chinese Academy of Medical Sciences. It has been a top-ranked hospital in China for over 80 years and has been recognized by Central Government agencies and local government agencies for its outstanding medical service and quality patient care with over 19 awards such as, "Top Ten Hospitals in Beijing" and "Top 100 National Hospitals." "The development of a Mandarin-language automation system user interface is the culmination of a significant Omnicell investment and demonstrates our unmatched commitment to bringing advanced medication automation solutions to the Chinese market," said Randall Lipps, Omnicell president, chairman and CEO. "We believe we are the first major supplier of automation to install Mandarin language ADCs in this market." Following the successful conversion of Omnicell's breakthrough G4 medication automation platform for the special language requirements of China, the company has announced a partnership with China Resources Beijing Pharmaceutical Co. Ltd., a subsidiary of China Resources Pharmaceutical Group, to distribute Omnicell automated medication dispensing systems in China. Early in 2011, the Chinese Ministry of Commerce released a five-year plan that commits the Chinese pharmaceutical distribution industry to consolidate into three primary pharmaceutical suppliers, one of which is China Resources Pharmaceutical. The plan further encourages pharmaceutical distribution companies to modernize the distribution process and improve the supply chain and control of medication.
Since this summer's market low, small-cap stocks have been outperforming large-cap stocks. Here are small caps with 'persistently strong top-line growth and improving fundamentals,' according to RBC Capital Markets.